| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adipokines may mediate the relationship between resting metabolic rates and bone mineral densities in obese women
|
Moradi, S.
|
|
2017
|
28 |
5 |
p. 1619-1629
|
artikel
|
| 2 |
A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
|
Morton, A.
|
|
2017
|
28 |
5 |
p. 1759
|
artikel
|
| 3 |
Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study
|
Carbone, L. D.
|
|
2017
|
28 |
5 |
p. 1631-1640
|
artikel
|
| 4 |
Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities
|
Marques, I. D. B.
|
|
2017
|
28 |
5 |
p. 1675-1683
|
artikel
|
| 5 |
Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study
|
Zhou, L.
|
|
2017
|
28 |
5 |
p. 1693-1698
|
artikel
|
| 6 |
Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
|
Fu, S. J.
|
|
2017
|
28 |
5 |
p. 1755-1756
|
artikel
|
| 7 |
Conclusions stand firm with additional data
|
Weaver, C. M.
|
|
2017
|
28 |
5 |
p. 1753-1754
|
artikel
|
| 8 |
Cost effective measures to standardize serum 25(OH)D values from completed studies
|
Sempos, C. T.
|
|
2017
|
28 |
5 |
p. 1503-1505
|
artikel
|
| 9 |
Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan
|
Mori, T.
|
|
2017
|
28 |
5 |
p. 1733-1744
|
artikel
|
| 10 |
Dietary potassium intake is beneficial to bone health in a low calcium intake population: the Korean National Health and Nutrition Examination Survey (KNHANES) (2008–2011)
|
Kong, S. H.
|
|
2017
|
28 |
5 |
p. 1577-1585
|
artikel
|
| 11 |
Effect of comorbidities on the association between age and hospital mortality after fall-related hip fracture in elderly patients
|
Padrón-Monedero, A.
|
|
2017
|
28 |
5 |
p. 1559-1568
|
artikel
|
| 12 |
Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis
|
Lee, S.-H.
|
|
2017
|
28 |
5 |
p. 1763
|
artikel
|
| 13 |
Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets
|
Colares Neto, G. P.
|
|
2017
|
28 |
5 |
p. 1685-1692
|
artikel
|
| 14 |
Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?
|
Ayus, J. C.
|
|
2017
|
28 |
5 |
p. 1543-1548
|
artikel
|
| 15 |
Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area
|
Chen, Y.-Y.
|
|
2017
|
28 |
5 |
p. 1711-1721
|
artikel
|
| 16 |
Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures
|
Harvey, N. C. W.
|
|
2017
|
28 |
5 |
p. 1507-1529
|
artikel
|
| 17 |
Observations following discontinuation of long-term denosumab therapy
|
McClung, M. R.
|
|
2017
|
28 |
5 |
p. 1723-1732
|
artikel
|
| 18 |
Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
|
Bone, H. G.
|
|
2017
|
28 |
5 |
p. 1745-1752
|
artikel
|
| 19 |
Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial
|
Merle, B.
|
|
2017
|
28 |
5 |
p. 1549-1558
|
artikel
|
| 20 |
Preceding and subsequent high- and low-trauma fracture patterns—a 13-year epidemiological study in females and males in Austria
|
Muschitz, C.
|
|
2017
|
28 |
5 |
p. 1609-1618
|
artikel
|
| 21 |
Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
|
Dede, A. D.
|
|
2017
|
28 |
5 |
p. 1761-1762
|
artikel
|
| 22 |
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
|
Kamimura, M.
|
|
2017
|
28 |
5 |
p. 1757-1758
|
artikel
|
| 23 |
Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism
|
Lee, J. H.
|
|
2017
|
28 |
5 |
p. 1667-1674
|
artikel
|
| 24 |
Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study
|
Du, Y.
|
|
2017
|
28 |
5 |
p. 1699-1709
|
artikel
|
| 25 |
Standardizing 25-hydroxyvitamin D data from the HunMen cohort
|
Jakab, E.
|
|
2017
|
28 |
5 |
p. 1653-1657
|
artikel
|
| 26 |
The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation
|
Landi, F.
|
|
2017
|
28 |
5 |
p. 1569-1576
|
artikel
|
| 27 |
The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture
|
Feng, Y.
|
|
2017
|
28 |
5 |
p. 1641-1652
|
artikel
|
| 28 |
The importance of physical function to people with osteoporosis
|
Kerr, C.
|
|
2017
|
28 |
5 |
p. 1597-1607
|
artikel
|
| 29 |
Use of proton pump inhibitors and mortality after hip fracture in a nationwide study
|
Brozek, W.
|
|
2017
|
28 |
5 |
p. 1587-1595
|
artikel
|
| 30 |
Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency
|
Mikula, A. L.
|
|
2017
|
28 |
5 |
p. 1659-1665
|
artikel
|
| 31 |
Worldwide prevalence and incidence of osteoporotic vertebral fractures
|
Ballane, G.
|
|
2017
|
28 |
5 |
p. 1531-1542
|
artikel
|
Tijdschrift beschrijving